AI
Thursday, January 03, 2013 7:23:09 PM
I'll go with what "Dr. Joseph Rubinfeld, co-founder of Amgen",....has to say Over any mssg brd Poster!!...
" in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. "
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83041680
-------------------
"The data demonstrated that when MANF is delivered directly to the primary brain region associated with Parkinson's called the substantia nigra, MANF significantly reduced behavioural deficits in the model, whereas GDNF (another therapeutic protein in Phase II trials) did not."
http://seekingalpha.com/article/1016221-finding-a-cure-for-parkinson-s
" in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. "
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83041680
-------------------
"The data demonstrated that when MANF is delivered directly to the primary brain region associated with Parkinson's called the substantia nigra, MANF significantly reduced behavioural deficits in the model, whereas GDNF (another therapeutic protein in Phase II trials) did not."
http://seekingalpha.com/article/1016221-finding-a-cure-for-parkinson-s
